Charles River Laboratories has raised its 2026 profit forecast following a strategic divestiture of non-core and underperforming assets, ...
Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, announced th...
Pre-Seed Round Co-Led By Freeflow Ventures and Lifespan Vision Ventures With Participation From Valuence Ventures, Eisai Innovation, SBI US Gateway Fun...
Bavarian Nordic A/S announced a new order valued at USD 22.5 million from the Public Health Agency of Canada (PHAC) for the Company’s mpox an...
Proceeds expected to fund global ENIGMA-TRS studies and extend cash runway beyond pivotal 12-week results, supporting development of evenamide as the p...
Total fourth quarter revenue of $878 million, an increase of 23% on a reported and core revenue basis, with Screening revenue of $695 million and Pre...
Wellumio, a New Zealand-based medical technology company developing a portable neuroimaging device for rapid, point-of-care stroke detection, has raised $7...
Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-...
A team from Knobbe Martens obtained a decisive win for medical device manufacturer Applied Medical against Medtronic, Inc. in an antitrust case involving...
BioSelective Capital Investments and Shayan Enterprises, LLC, a Utah-based risk-capital investment firm, announced the successful acquisition of Bi...
Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging...
SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) The...
Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage biotechnology company committed to developing next-generation siRNA therapies, announ...
BioCryst Pharmaceuticals, Inc. announced that it has completed its acquisition of Astria Therapeutics, Inc., initially announced on October 14, 202...
© 2026 Biopharma Boardroom. All Rights Reserved.
